The new cancer killer

Toby Fagan, Staff Writer

How the trojan horse is able to kill cancer. (Credit: The university of Edinburough)

Researchers at the University of Edinburgh may have found the cure for cancer. New advancements have allowed them to develop a Trojan Horse counter virus that is small enough that cancer cells no longer reject it. This ability to create something that acts like food to cancer cells but then kills it will greatly advance how we treat cancer. Reliance upon things like chemotherapy and transplants to treat cancer may be eliminated, creating a world where cancer can have a survival rate of 60-90%. This massive jump from the 50-50 chance you had before means that we have taken a huge step towards a brighter tomorrow.  

The innovation involved in this technology is what truly sets it apart. It is a light-sensitive drug, so it won’t activate until exposed to light, allowing it to invade cancerous cells before they recognize it as a threat, and when they do, it’s too late. Second is the size. Previously, Trojan Horse methods were too large. Cancer cells weren’t able to digest the particle and thus disregarded it, choosing smaller particles and growing more dangerous and needing alternative forms of treatment. With this new particle, cancer cells immediately determine that they are food and digest the particle and once digested it is activated by light exposure and kills the cell. Unfortunately, this new advancement has only recently begun lab testing and has not started animal or human testing, meaning effective usage may be delayed for a few years. Even with this setback, we look forward to its practical application and it becomes a step towards a cure. Read the original article here: https://www.ed.ac.uk/inflammation-research/news-events/light-sensitive-drug-acts-as-trojan-horse-to-kill